<i>YAP1</i>acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto(National Cancer Institute), Piergiorgio Modena(Ospedale Sant'Anna)OncotargetMarch 23, 201410.18632/oncotarget.1844Cited by 74SaveCiteExport RISWatch citationsRelated PapersClinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries|Journal of Clinical Oncology|2018|433